Indication

Bacterial vaginosis

Bacterial vaginosis is a common dysbiosis of the lower female genital tract, predominantly affecting reproductive-aged females. Read more about Bacterial vaginosis

43 drugs 37 manufacturers

Advertisement

Drugs that treat it

Common Bacterial vaginosis therapies.

Showing 1–9 of 43 drugs

Filter & compare in the drug finder →Opens the drug finder with Bacterial vaginosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bacterial vaginosis.

Bacterial vaginosis is a common dysbiosis of the lower female genital tract, predominantly affecting reproductive-aged females.

It is pathophysiologically characterized by a marked depletion of protective, hydrogen peroxide–producing *Lactobacillus* species and a concurrent polymicrobial overgrowth of facultative and obligate anaerobic organisms, such as *Gardnerella vaginalis*, *Atopobium vaginae*, and *Prevotella* species.

Clinically, affected patients often present with an elevated vaginal pH above 4.5, clue cells on wet mount microscopy, and an off-white or grayish, homogeneous, thin vaginal discharge accompanied by a characteristic amine or "fishy" odor.

Although frequently asymptomatic or mildly symptomatic, the condition increases susceptibility to sexually transmitted infections and is associated with adverse gynecologic and obstetric outcomes, including pelvic inflammatory disease and preterm birth.

Personalize your experience

Follow Bacterial vaginosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it